Concurrent with cardiovascular benefits, GLP-1 RAs have demonstrated promising renal protective effects, with recent meta-analyses revealing significant reductions in clinically important kidney events and kidney failure [8,9]. The gene discussed is GLP1R; the disease is kidney failure.